Retaglutide and tirzepatide are newer GLP-1 receptor agonists gaining popularity as effective treatment options for type 2 diabetes. These medications promote insulin secretion from the pancreas, inhibit glucagon https://finnianpwdq411746.wikiannouncing.com/7624396/emerging_therapies_for_type_2_diabetes